AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $111 | -68.4% | 12,166 | -75.2% | 0.00% | – |
| Q4 2022 | $351 | -100.0% | 49,096 | -66.1% | 0.00% | -100.0% |
| Q3 2022 | $726,000 | +109.2% | 144,957 | +1.7% | 0.00% | – |
| Q2 2022 | $347,000 | -65.2% | 142,577 | -2.4% | 0.00% | -100.0% |
| Q1 2022 | $998,000 | -21.6% | 146,142 | -7.3% | 0.00% | 0.0% |
| Q4 2021 | $1,273,000 | +121.8% | 157,637 | +168.7% | 0.00% | 0.0% |
| Q3 2021 | $574,000 | +144.3% | 58,672 | +67.8% | 0.00% | – |
| Q2 2021 | $235,000 | -25.6% | 34,970 | 0.0% | 0.00% | – |
| Q1 2021 | $316,000 | +58.8% | 34,970 | +17.1% | 0.00% | – |
| Q4 2020 | $199,000 | +4875.0% | 29,860 | +4876.7% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | 0.0% | 600 | +50.0% | 0.00% | – |
| Q3 2017 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |